WVU oncologist researches new treatment for cervical and vaginal cancers

Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight dangerous cervical and vaginal cancer better.

WVU board approves new policies governing ethics, identity theft and tobacco

The West Virginia University Board of Governors today (Feb. 8) gave final approval to a trio of updated policies, and also sent out for comment the latest updated rule as it works to complete policy revisions in the wake of the adoption of laws permitting more independence from the state Higher Education Policy Commission. The three rules, unanimously approved, deal with conflicts of interest, outside consulting and ethics; identify theft detection and prevention; and a tobacco-free campus.

WVU researchers pinpoint factor that predicts unplanned hospital readmissions

New research from West Virginia University suggests a widely used index to assess hospital patients’ risk of readmission may have a blind spot. Physicians and nurses use a tool called the “LACE index” to identify which patients are most likely to be readmitted to the hospital because symptoms come back or complications arise. But research out of the Health Sciences Center suggests the index fails to consider a key variables that could improve predictions in West Virginia: whether patients are on Medicaid.

WVU researchers investigate treating post-stroke depression with magnetic fields

Post-stroke depression stems from the cardiovascular changes in the brain that lead to a stroke in the first place. It’s a type of depression that scientists are just now starting to probe. At the West Virginia University School of Medicine, a team of researchers is taking a bench-to-bedside look at whether magnetic fields can help treat this unexplored mood disorder.

WVU Cancer Institute studies new treatment for colorectal cancer using novel drug combination

Richard Goldberg, who directs the West Virginia University Cancer Institute, is searching for new ways to slow colorectal cancer’s progression. In a recent study, he and an international team of scientists investigated a new drug combination for treating metastatic colorectal cancer in patients who had no—or only temporary—success with conventional chemotherapy treatments.

WVU researcher seeks vaccine to prevent lethal pneumonia

About half of all people with cystic fibrosis, the most common genetic disorder in the United States, die from a lung disease before they turn 40. A form of pneumonia called Pseudomonas aeruginosa is a likely culprit. These bacteria have become so hard to treat that the Centers for Disease Control deemed it a serious threat to the nation.

WVU chemists find new frontier for pharmaceutical development

West Virginia University chemists have developed an experiment to improve the efficiency of creating new medicine. The research, conducted by Associate Professor of Chemistry Jessica Hoover and doctoral student Robert Crovak, was published earlier this year in the Journal of the American Chemical Society, a top chemistry-focused journal

WVU researchers investigate how hospital lighting may hinder patient recovery

Now that Daylight Saving Time has ended, cyclists are attaching lights to their helmets, and dog walkers are storing flashlights next to their leashes. But one place that won’t get darker with the time change is the hospital. New research out of West Virginia University illuminates how the round-the-clock brightness of hospital rooms may stymie some patients’ recovery.